Forecasts
Financial Statements
AI Powered Summary
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Ask AI
Standalone Quarterly Results (in ₹ Crores)
Standalone Profit Loss (in ₹ Crores)
Standalone Balance Sheet (in ₹ Crores)
Standalone Cash Flows (in ₹ Crores)
Projection
Documents
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI


Frequently Asked Questions about Pentokey Organy (India) Ltd
Pentokey Organy (India) Ltd (PNTKYOR) is currently trading at 35.99 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Pentokey Organy (India) Ltd is primarily engaged in trading pharmaceutical-related chemical products like Acetic Acid, Ethyl Acetate, and Acetaldehyde. Ethyl Acetate is gaining popularity as a solvent, replacing petroleum-based counterparts in various markets. The company has strategically shifted from producing to purchasing Acetic Acid due to competitive market pricing. Pentokey Organy expanded its production capacity of Ethanol significantly due to favorable conditions in Maharashtra.
Over the past 52 weeks, Pentokey Organy (India) Ltd has traded between a low of ₹27.50 and a high of ₹63.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Pentokey Organy (India) Ltd has a market capitalization of approximately 22.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Pentokey Organy (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 42.85 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 22.57 Cr, Pentokey Organy (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Pentokey Organy (India) Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Pentokey Organy (India) Ltd is 42.85. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

